CureVac: EU in chaos: 225 million doses ordered
The German pharmaceutical company CureVac is not in good shape: yesterday it was announced that the efficacy of its Covid vaccine, so eagerly awaited in Europe, is only 47% (the other mRNA vaccines approved by the Ema so far have an average efficacy of over 90%).